United States Biotechnology & Medical Research

Palisade Bio Inc (PALI)

Track

Track

Palisade Bio Inc. experienced notable insider trading activity over the past 90 days, totaling ten transactions. While Robert Baltera Jr. consistently purchased shares, executives including the CEO and Chief Medical Officer executed significant sales. This net negative value of approximately $159,697 occurred alongside a 20.1% stock price increase, following the most recent results financiers.
Ticker: PALI Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Palisade Bio Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Baltera Robert Jr. Non-Executive Director
Transaction date
Purchase
Price
403.20
Quantity 58,901 -48.8%
Value US$1,686,441
Baltera Robert Jr. Non-Executive Director
Transaction date
Purchase
Price
406.30
Quantity 59,619 -40.2%
Value US$3,706,298
Baltera Robert Jr. Non-Executive Director
Transaction date
Purchase
Price
10.14
Quantity 32,890 +29.8%
Value US$4,863,275
1.6
Jones Mitchell Lawrence Chief Medical Officer Officer
Transaction date
Sale
Price
2.05
Quantity 51,880 -35.6%
Value US$106,536
1.7
Finley John David CEO, CFO Executive Director
Transaction date
Sale
Price
2.07
Quantity 146,798 -40.3%
Value US$303,343
1.6
Jones Mitchell Lawrence Officer Officer
Transaction date
Proposed sale
Price
2.04
Quantity 53,000
Value US$108,120
1.7
Finley John David Officer Officer
Transaction date
Proposed sale
Price
2.07
Quantity 146,798
Value US$303,343
Baltera Robert Jr. Non-Executive Director
Transaction date
Purchase
Price
2.05
Quantity 20,000 +5.5%
Value US$41,040
Baltera Robert Jr. Non-Executive Director
Transaction date
Purchase
Price
1.98
Quantity 10,000 +2.8%
Value US$19,800
Baltera Robert Jr. Non-Executive Director
Transaction date
Purchase
Price
1.98
Quantity 20,000 +5.9%
Value US$39,600
1.6
Jones Mitchell Lawrence Chief Medical Officer Officer
Transaction date
Sale
Price
1.75
Quantity 1,989 -13.0%
Value US$3,481
1.7
Finley John David CEO, CFO Executive Director
Transaction date
Sale
Price
1.75
Quantity 3,896 -12.5%
Value US$6,818
3.2
Williams Donald Allen Non-Executive Director
Transaction date
Purchase
Price
1.67
Quantity 5,000 +87.3%
Value US$8,356
3.2
Williams Donald Allen Non-Executive Director
Transaction date
Purchase
Price
1.88
Quantity 5,000 +686.8%
Value US$9,400
3.2
Williams Donald Allen Non-Executive Director
Transaction date
Purchase
Price
4.86
Quantity 1,000 +inf%
Value US$4,863
1.7
Finley John David CEO, CFO, Director Executive Director
Transaction date
Purchase
Price
4.81
Quantity 1,000 +13.4%
Value US$4,810
1.7
Finley John David CEO, CFO, Director Executive Director
Transaction date
Purchase
Price
0.47
Quantity 10,000 +13.4%
Value US$4,692
3.2
Williams Donald Allen Non-Executive Director
Transaction date
Purchase
Price
0.61
Quantity 10,000 +50.0%
Value US$6,050
1.7
Finley John David CEO, CFO, Director Executive Director
Transaction date
Purchase
Price
0.56
Quantity 10,000 +15.5%
Value US$5,590
1.7
Finley John David CEO, CFO, Director Executive Director
Transaction date
Purchase
Price
0.54
Quantity 15,000 +52.8%
Value US$8,088
3.2
Williams Donald Allen Non-Executive Director
Transaction date
Purchase
Price
0.54
Quantity 20,000 +inf%
Value US$10,800
1.0
Trenschel Robert J. Non-Executive Director
Transaction date
Sale
Price
0.64
Quantity 300 -100.0%
Value US$192
1.7
Finley John David CEO, CFO, Director Executive Director
Transaction date
Purchase
Price
0.66
Quantity 15,000 +112.0%
Value US$9,825
1.7
Finley John David Chief Financial Officer Officer
Transaction date
Purchase
Price
0.14
Quantity 19,481 +15.1%
Value US$2,799
1.7
Finley John David Chief Financial Officer Officer
Transaction date
Purchase
Price
0.16
Quantity 7,350 +6.0%
Value US$1,176
2.1
Hallam Thomas Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.25
Quantity 40,000 +227.4%
Value US$10,000
1.7
Finley John David Chief Financial Officer Officer
Transaction date
Purchase
Price
0.25
Quantity 100,000 +456.7%
Value US$25,000
2.1
Hallam Thomas Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.18
Quantity 10,000 +131.7%
Value US$11,800
1.7
Finley John David Chief Financial Officer Officer
Transaction date
Purchase
Price
1.09
Quantity 7,500 +52.1%
Value US$8,174
1.0
Trenschel Robert J. Non-Executive Director
Transaction date
Purchase
Price
2.98
Quantity 2,142 +16.7%
Value US$6,383
1.0
Trenschel Robert J. Non-Executive Director
Transaction date
Purchase
Price
2.89
Quantity 3,400 +36.0%
Value US$9,826
1.0
Trenschel Robert J. Non-Executive Director
Transaction date
Purchase
Price
2.75
Quantity 5,000 +112.2%
Value US$13,750
1.0
Trenschel Robert J. Non-Executive Director
Transaction date
Purchase
Price
2.78
Quantity 2,707 +154.7%
Value US$7,525
1.0
Trenschel Robert J. Non-Executive Director
Transaction date
Purchase
Price
2.75
Quantity 1,750 +inf%
Value US$4,812
Daly Richard J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
4.00
Quantity 7,500 +47.4%
Value US$30,000
LLOYD JONES JONATHAN BRIAN Chief Financial Officer
Transaction date
Purchase
Price
5.50
Quantity 5,455 +226.9%
Value US$30,002
Daly Richard J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.86
Quantity 2,591 +19.6%
Value US$10,001
Daly Richard J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
3.52
Quantity 2,841 +27.4%
Value US$10,000
Daly Richard J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.31
Quantity 32,259 +31.4%
Value US$10,000
Daly Richard J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.28
Quantity 35,715 +53.3%
Value US$10,000
Daly Richard J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.28
Quantity 35,715 +114.3%
Value US$10,000
LLOYD JONES JONATHAN BRIAN Chief Financial Officer Officer
Transaction date
Purchase
Price
0.32
Quantity 31,250 +inf%
Value US$10,000
Daly Richard J Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.32
Quantity 31,250 +inf%
Value US$10,000
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.09
Quantity 25,000 -2.9%
Value US$27,250
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.18
Quantity 25,000 -2.9%
Value US$29,500
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.17
Quantity 25,000 -2.8%
Value US$29,355
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.13
Quantity 25,000 -2.7%
Value US$28,190
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.23
Quantity 25,000 -2.6%
Value US$30,690
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.31
Quantity 25,000 -2.6%
Value US$32,725
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.26
Quantity 25,000 -2.5%
Value US$31,460
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.64
Quantity 25,000 -2.4%
Value US$41,000
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.52
Quantity 25,000 -2.4%
Value US$38,078
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
4.09
Quantity 6,000 -1.2%
Value US$24,540
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
2.78
Quantity 6,000 -1.2%
Value US$16,680
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
4.17
Quantity 6,000 -1.2%
Value US$25,020
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
4.25
Quantity 6,000 -1.2%
Value US$25,500
OLDAKER WILLIAM CLYDE Non-Executive Director
Transaction date
Purchase
Price
3.50
Quantity 985 +inf%
Value US$3,448
OLDAKER WILLIAM CLYDE Non-Executive Director
Transaction date
Purchase
Price
3.50
Quantity 14,250 +13.9%
Value US$49,874
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
3.54
Quantity 6,000 -1.2%
Value US$21,255
GARR RICHARD CEO Executive Director
Transaction date
Sale
Price
4.25
Quantity 7,000 -2.8%
Value US$29,750
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
4.11
Quantity 6,000 -1.1%
Value US$24,638
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
4.04
Quantity 6,000 -1.1%
Value US$24,249
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
2.35
Quantity 10,000 -1.4%
Value US$23,458
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
2.44
Quantity 10,000 -1.4%
Value US$24,446
JOHE KARL Chief Scientific Officer
Transaction date
Sale
Price
2.62
Quantity 10,000 -1.4%
Value US$26,241
JOHE KARL Chief Scientific Officer
Transaction date
Sale
Price
2.61
Quantity 10,000 -1.4%
Value US$26,094
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.55
Quantity 20,000 -2.7%
Value US$30,986
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.62
Quantity 12,800 -1.7%
Value US$20,780
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.40
Quantity 12,800 -1.7%
Value US$17,856
GARR RICHARD CEO Executive Director
Transaction date
Sale
Price
1.42
Quantity 6,000 -2.8%
Value US$8,520
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.51
Quantity 12,800 -1.6%
Value US$19,301
JOHE KARL Chief Scientific Officer
Transaction date
Sale
Price
1.13
Quantity 12,800 -1.6%
Value US$14,520
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.14
Quantity 12,800 -1.6%
Value US$14,546
GARR RICHARD CEO Executive Director
Transaction date
Sale
Price
1.15
Quantity 12,000 -5.3%
Value US$13,800
JOHE KARL Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.18
Quantity 12,800 -1.6%
Value US$15,104
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-10 2026-07-09 B Purchase
Baltera Robert Jr.
Non-Executive Director
58,901 -48.8%
403.20
US$1,686,441 		58,901 -48.8% 403.20 US$1,686,441
2026-07-10 2026-07-08 B Purchase
Baltera Robert Jr.
Non-Executive Director
59,619 -40.2%
406.30
US$3,706,298 		59,619 -40.2% 406.30 US$3,706,298
2026-07-08 2026-07-07 B Purchase
Baltera Robert Jr.
Non-Executive Director
32,890 +29.8%
10.14
US$4,863,275 		32,890 +29.8% 10.14 US$4,863,275
2026-07-08 2026-07-07 S Sale
1.6
Jones Mitchell Lawrence

Chief Medical Officer

Officer
51,880 -35.6%
2.05
US$106,536 		51,880 -35.6% 2.05 US$106,536
2026-07-08 2026-07-07 S Sale
1.7
Finley John David

CEO, CFO

Executive Director
146,798 -40.3%
2.07
US$303,343 		146,798 -40.3% 2.07 US$303,343
2026-07-07 2026-07-07 PrS Proposed sale
1.6
Jones Mitchell Lawrence

Officer

Officer
53,000
2.04
US$108,120 		53,000 2.04 US$108,120
2026-07-07 2026-07-07 PrS Proposed sale
1.7
Finley John David

Officer

Officer
146,798
2.07
US$303,343 		146,798 2.07 US$303,343
2026-07-08 2026-07-06 B Purchase
Baltera Robert Jr.
Non-Executive Director
20,000 +5.5%
2.05
US$41,040 		20,000 +5.5% 2.05 US$41,040
2026-07-06 2026-07-02 B Purchase
Baltera Robert Jr.
Non-Executive Director
10,000 +2.8%
1.98
US$19,800 		10,000 +2.8% 1.98 US$19,800
2026-07-06 2026-07-01 B Purchase
Baltera Robert Jr.
Non-Executive Director
20,000 +5.9%
1.98
US$39,600 		20,000 +5.9% 1.98 US$39,600
2026-02-13 2026-02-12 S Sale
1.6
Jones Mitchell Lawrence

Chief Medical Officer

Officer
1,989 -13.0%
1.75
US$3,481 		1,989 -13.0% 1.75 US$3,481
2026-02-13 2026-02-12 S Sale
1.7
Finley John David

CEO, CFO

Executive Director
3,896 -12.5%
1.75
US$6,818 		3,896 -12.5% 1.75 US$6,818
2026-01-21 2026-01-16 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
5,000 +87.3%
1.67
US$8,356 		5,000 +87.3% 1.67 US$8,356
2026-01-13 2026-01-09 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
5,000 +686.8%
1.88
US$9,400 		5,000 +686.8% 1.88 US$9,400
2024-05-29 2024-05-28 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
1,000 +inf%
4.86
US$4,863 		1,000 +inf% 4.86 US$4,863
2024-05-28 2024-05-24 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
1,000 +13.4%
4.81
US$4,810 		1,000 +13.4% 4.81 US$4,810
2024-02-07 2024-02-06 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
10,000 +13.4%
0.47
US$4,692 		10,000 +13.4% 0.47 US$4,692
2024-02-01 2024-01-31 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
10,000 +50.0%
0.61
US$6,050 		10,000 +50.0% 0.61 US$6,050
2024-02-01 2024-01-31 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
10,000 +15.5%
0.56
US$5,590 		10,000 +15.5% 0.56 US$5,590
2023-09-29 2023-09-27 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
15,000 +52.8%
0.54
US$8,088 		15,000 +52.8% 0.54 US$8,088
2023-09-29 2023-09-27 B Purchase
3.2
Williams Donald Allen
Non-Executive Director
20,000 +inf%
0.54
US$10,800 		20,000 +inf% 0.54 US$10,800
2023-09-15 2023-09-14 S Sale
1.0
Trenschel Robert J.
Non-Executive Director
300 -100.0%
0.64
US$192 		300 -100.0% 0.64 US$192
2023-09-14 2023-09-13 B Purchase
1.7
Finley John David

CEO, CFO, Director

Executive Director
15,000 +112.0%
0.66
US$9,825 		15,000 +112.0% 0.66 US$9,825
2022-09-02 2022-09-01 B Purchase
1.7
Finley John David

Chief Financial Officer

Officer
19,481 +15.1%
0.14
US$2,799 		19,481 +15.1% 0.14 US$2,799
2022-08-25 2022-08-23 B Purchase
1.7
Finley John David

Chief Financial Officer

Officer
7,350 +6.0%
0.16
US$1,176 		7,350 +6.0% 0.16 US$1,176
2022-08-18 2022-08-16 B Purchase
2.1
Hallam Thomas

Chief Executive Officer

Executive Director
40,000 +227.4%
0.25
US$10,000 		40,000 +227.4% 0.25 US$10,000
2022-08-18 2022-08-16 B Purchase
1.7
Finley John David

Chief Financial Officer

Officer
100,000 +456.7%
0.25
US$25,000 		100,000 +456.7% 0.25 US$25,000
2022-03-29 2022-03-28 B Purchase
2.1
Hallam Thomas

Chief Executive Officer

Executive Director
10,000 +131.7%
1.18
US$11,800 		10,000 +131.7% 1.18 US$11,800
2022-03-25 2022-03-24 B Purchase
1.7
Finley John David

Chief Financial Officer

Officer
7,500 +52.1%
1.09
US$8,174 		7,500 +52.1% 1.09 US$8,174
2021-09-13 2021-09-10 B Purchase
1.0
Trenschel Robert J.
Non-Executive Director
2,142 +16.7%
2.98
US$6,383 		2,142 +16.7% 2.98 US$6,383
2021-09-13 2021-09-09 B Purchase
1.0
Trenschel Robert J.
Non-Executive Director
3,400 +36.0%
2.89
US$9,826 		3,400 +36.0% 2.89 US$9,826
2021-09-13 2021-09-08 B Purchase
1.0
Trenschel Robert J.
Non-Executive Director
5,000 +112.2%
2.75
US$13,750 		5,000 +112.2% 2.75 US$13,750
2021-09-13 2021-09-07 B Purchase
1.0
Trenschel Robert J.
Non-Executive Director
2,707 +154.7%
2.78
US$7,525 		2,707 +154.7% 2.78 US$7,525
2021-09-13 2021-08-31 B Purchase
1.0
Trenschel Robert J.
Non-Executive Director
1,750 +inf%
2.75
US$4,812 		1,750 +inf% 2.75 US$4,812
2017-05-18 2017-05-17 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
7,500 +47.4%
4.00
US$30,000 		7,500 +47.4% 4.00 US$30,000
2017-03-27 2017-03-24 B Purchase LLOYD JONES JONATHAN BRIAN

Chief Financial Officer
5,455 +226.9%
5.50
US$30,002 		5,455 +226.9% 5.50 US$30,002
2017-02-27 2017-02-24 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
2,591 +19.6%
3.86
US$10,001 		2,591 +19.6% 3.86 US$10,001
2017-01-27 2017-01-25 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
2,841 +27.4%
3.52
US$10,000 		2,841 +27.4% 3.52 US$10,000
2016-12-30 2016-12-23 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
32,259 +31.4%
0.31
US$10,000 		32,259 +31.4% 0.31 US$10,000
2016-11-28 2016-11-25 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
35,715 +53.3%
0.28
US$10,000 		35,715 +53.3% 0.28 US$10,000
2016-10-27 2016-10-25 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
35,715 +114.3%
0.28
US$10,000 		35,715 +114.3% 0.28 US$10,000
2016-09-26 2016-09-23 B Purchase LLOYD JONES JONATHAN BRIAN

Chief Financial Officer

Officer
31,250 +inf%
0.32
US$10,000 		31,250 +inf% 0.32 US$10,000
2016-09-26 2016-09-23 B Purchase Daly Richard J

Chief Executive Officer

Executive Director
31,250 +inf%
0.32
US$10,000 		31,250 +inf% 0.32 US$10,000
2015-11-16 2015-11-16 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.9%
1.09
US$27,250 		25,000 -2.9% 1.09 US$27,250
2015-11-09 2015-11-09 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.9%
1.18
US$29,500 		25,000 -2.9% 1.18 US$29,500
2015-11-03 2015-11-02 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.8%
1.17
US$29,355 		25,000 -2.8% 1.17 US$29,355
2015-10-27 2015-10-26 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.7%
1.13
US$28,190 		25,000 -2.7% 1.13 US$28,190
2015-10-19 2015-10-19 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.6%
1.23
US$30,690 		25,000 -2.6% 1.23 US$30,690
2015-10-13 2015-10-12 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.6%
1.31
US$32,725 		25,000 -2.6% 1.31 US$32,725
2015-10-05 2015-10-05 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.5%
1.26
US$31,460 		25,000 -2.5% 1.26 US$31,460
2015-09-28 2015-09-28 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.4%
1.64
US$41,000 		25,000 -2.4% 1.64 US$41,000
2015-09-21 2015-09-21 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
25,000 -2.4%
1.52
US$38,078 		25,000 -2.4% 1.52 US$38,078
2014-09-03 2014-09-02 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
4.09
US$24,540 		6,000 -1.2% 4.09 US$24,540
2014-08-04 2014-08-01 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
2.78
US$16,680 		6,000 -1.2% 2.78 US$16,680
2014-07-01 2014-07-01 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
4.17
US$25,020 		6,000 -1.2% 4.17 US$25,020
2014-06-02 2014-06-02 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
4.25
US$25,500 		6,000 -1.2% 4.25 US$25,500
2014-05-07 2014-05-05 B Purchase OLDAKER WILLIAM CLYDE Non-Executive Director
985 +inf%
3.50
US$3,448 		985 +inf% 3.50 US$3,448
2014-05-07 2014-05-05 B Purchase OLDAKER WILLIAM CLYDE Non-Executive Director
14,250 +13.9%
3.50
US$49,874 		14,250 +13.9% 3.50 US$49,874
2014-05-05 2014-05-01 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.2%
3.54
US$21,255 		6,000 -1.2% 3.54 US$21,255
2014-04-23 2014-04-22 S Sale GARR RICHARD

CEO

Executive Director
7,000 -2.8%
4.25
US$29,750 		7,000 -2.8% 4.25 US$29,750
2014-04-02 2014-04-01 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.1%
4.11
US$24,638 		6,000 -1.1% 4.11 US$24,638
2014-03-21 2014-03-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
6,000 -1.1%
4.04
US$24,249 		6,000 -1.1% 4.04 US$24,249
2013-11-07 2013-10-21 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
10,000 -1.4%
2.35
US$23,458 		10,000 -1.4% 2.35 US$23,458
2013-10-21 2013-10-18 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
10,000 -1.4%
2.44
US$24,446 		10,000 -1.4% 2.44 US$24,446
2013-09-23 2013-09-20 S Sale JOHE KARL

Chief Scientific Officer
10,000 -1.4%
2.62
US$26,241 		10,000 -1.4% 2.62 US$26,241
2013-09-19 2013-09-19 S Sale JOHE KARL

Chief Scientific Officer
10,000 -1.4%
2.61
US$26,094 		10,000 -1.4% 2.61 US$26,094
2013-08-21 2013-08-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
20,000 -2.7%
1.55
US$30,986 		20,000 -2.7% 1.55 US$30,986
2013-07-22 2013-07-22 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.7%
1.62
US$20,780 		12,800 -1.7% 1.62 US$20,780
2013-06-21 2013-06-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.7%
1.40
US$17,856 		12,800 -1.7% 1.40 US$17,856
2013-06-11 2013-06-07 S Sale GARR RICHARD

CEO

Executive Director
6,000 -2.8%
1.42
US$8,520 		6,000 -2.8% 1.42 US$8,520
2013-05-21 2013-05-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.6%
1.51
US$19,301 		12,800 -1.6% 1.51 US$19,301
2013-04-23 2013-04-22 S Sale JOHE KARL

Chief Scientific Officer
12,800 -1.6%
1.13
US$14,520 		12,800 -1.6% 1.13 US$14,520
2013-03-22 2013-03-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.6%
1.14
US$14,546 		12,800 -1.6% 1.14 US$14,546
2013-02-26 2013-02-25 S Sale GARR RICHARD

CEO

Executive Director
12,000 -5.3%
1.15
US$13,800 		12,000 -5.3% 1.15 US$13,800
2013-02-21 2013-02-20 S Sale JOHE KARL

Chief Scientific Officer

Executive Director
12,800 -1.6%
1.18
US$15,104 		12,800 -1.6% 1.18 US$15,104
Explore more

More insider trading research around Palisade Bio Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America